BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Hippocampus
,
Hematopoietic cell
,
Trichostatin A
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pd 20
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
Gastrointestinal stromal tumor GIST882 cells with COP1 siRNA knockdown and treated with PD0325901
Embryonic stem cell gene expression in response to inducible depletion of Max
MDCK cells treated with hepatocyte growth factor and MAPK ERK pathway inhibitors
Embryonic stem and primordial germ cells derived and maintained in different culture conditions
Explore Curated Studies Results
Literature
Most Relevant Literature
One- vs Two- vertical muscle surgery in the management of unilateral superior oblique muscle palsy w…
Universal health coverage: a commitment to essential surgical, obstetric, and anesthesia care, World…
Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DB…
The system uranium-palladium-boron with U(2.5)Pd(20.5)B(6), a new heavy fermion compound.
Microstructural white matter changes underlying speech deficits in Parkinson's disease.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer
Study of ADI-PEG 20 in Patients With Advanced Melanoma
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers
MIRT and Rotigotine in the Early Stage of PD
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ